Treatments for biomedical abnormalities associated with autism spectrum disorder.
about
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.Sulforaphane treatment of autism spectrum disorder (ASD).Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders.The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder.Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia.Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.On the use of carnosine and antioxidants: A letter from Russia.New treatment perspectives in autism spectrum disorders.The Pivotal Role of Aldehyde Toxicity in Autism Spectrum Disorder: The Therapeutic Potential of Micronutrient Supplementation.Bioenergetic variation is related to autism symptomatology.Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings.Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum DisorderSocial Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
P2860
Q26744037-4601137B-D09F-4FCC-A540-7233DE750A52Q30363954-7C845307-9FD9-45EC-BADC-878FC3E4A873Q30410996-D4F5F151-3871-4C03-8A89-D1F329EF654FQ34442394-E8721281-6114-4BDC-94D3-56A0CF562BBAQ34542848-EA3D0975-278F-4578-8731-8E713B67F023Q35139145-726C81DC-AB78-4F21-B88C-DCA94F7196F0Q37474219-43743EB6-BA44-4BC0-8230-EFECEBEC1788Q37676044-E4595381-E34D-47FE-BBF4-8B22E5FBC52FQ38953210-BBE70290-CBA7-464D-8419-B64DE61887C0Q39384617-67D21A4B-553B-4942-97E9-6402F8FD1B10Q41781708-C78F41EE-7EF5-4F7F-86B8-8E5B5C60BE24Q41906721-23D9A3F6-B50F-4815-879A-65B2E831106AQ41913940-454C44B1-08BD-4022-93F7-88C6F00FAEE6Q44602403-DD5B6CF4-F8D1-49E0-B098-436AA416BCECQ53412661-E5C82E0C-6223-4152-8B1F-C3D63991BF3CQ55079878-B0DAF7D8-3B65-4026-970A-2F92B0594AF5Q57922552-048E5DF3-D112-4926-9B5D-18DA1D68D635Q58780865-ED85C941-4C65-4768-9DFA-B604DAD61D2F
P2860
Treatments for biomedical abnormalities associated with autism spectrum disorder.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@ast
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@en
type
label
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@ast
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@en
prefLabel
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@ast
Treatments for biomedical abnormalities associated with autism spectrum disorder.
@en
P2860
P356
P1476
Treatments for biomedical abnormalities associated with autism spectrum disorder
@en
P2093
Richard Eugene Frye
P2860
P356
10.3389/FPED.2014.00066
P577
2014-06-27T00:00:00Z